These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36544758)

  • 21. The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance.
    Akegbe H; Onyeaka H; Michael Mazi I; Alex Olowolafe O; Dolapo Omotosho A; Olatunji Oladunjoye I; Amuda Tajudeen Y; Seun Ofeh A
    Vaccine X; 2023 Aug; 14():100320. PubMed ID: 37293248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Pandemic and Africa: From the Situation in Zimbabwe to a Case for Precision Herbal Medicine.
    Dandara C; Dzobo K; Chirikure S
    OMICS; 2021 Apr; 25(4):209-212. PubMed ID: 32654634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 as a catalyst for vaccine manufacturing: A South African experience.
    Moore PL; Gray G
    Cell Host Microbe; 2023 Jun; 31(6):839-842. PubMed ID: 37321166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing vaccinology expertise for Africa: fifteen years and counting.
    Amponsah-Dacosta E; Muloiwa R; Wiysonge CS; Gold M; Hussey G; Kagina BM
    Pan Afr Med J; 2021; 38():313. PubMed ID: 34285736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEPFAR's Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa.
    Holtzman CW; Godfrey C; Ismail L; Raizes E; Ake JA; Tefera F; Okutoyi S; Siberry GK
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):26-36. PubMed ID: 34982406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19: A perspective on Africa's capacity and response.
    Dzinamarira T; Dzobo M; Chitungo I
    J Med Virol; 2020 Nov; 92(11):2465-2472. PubMed ID: 32525568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building the Momentum for A Stronger Pharmaceutical System in Africa.
    Ussai S; Chillotti C; Stochino E; Deidda A; Ambu G; Anania L; Boccalini A; Colombo F; Ferrari A; Pala D; Puddu E; Rapallo G; Pistis M
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccines and a perspective on Africa.
    Mantovani A; Rescigno M; Forni G; Tognon F; Putoto G; Ictho J; Lochoro P
    Trends Immunol; 2023 Mar; 44(3):172-187. PubMed ID: 36709083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.
    Lamptey E; Senkyire EK; Benita DA; Boakye EO
    Clin Exp Vaccine Res; 2022 Jan; 11(1):82-88. PubMed ID: 35223668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinology in sub-Saharan Africa.
    Moïsi J; Madhi SA; Rees H
    BMJ Glob Health; 2019; 4(5):e001363. PubMed ID: 31637022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenges to a successful COVID-19 vaccination programme in Africa.
    Ayenigbara IO; Adegboro JS; Ayenigbara GO; Adeleke OR; Olofintuyi OO
    Germs; 2021 Sep; 11(3):427-440. PubMed ID: 34722365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in vaccine development for infectious diseases-a Keystone Symposia report.
    Cable J; Graham BS; Koup RA; Seder RA; Karikó K; Pardi N; Barouch DH; Sharma B; Rauch S; Nachbagauer R; Forsell MNE; Schotsaert M; Ellebedy AH; Loré K; Irvine DJ; Pilkington E; Tahtinen S; Thompson EA; Feraoun Y; King NP; Saunders K; Alter G; Moin SM; Sliepen K; Karlsson Hedestam GB; Wardemann H; Pulendran B; Doria-Rose NA; He WT; Juno JA; Ataca S; Wheatley AK; McLellan JS; Walker LM; Lederhofer J; Lindesmith LC; Wille H; Hotez PJ; Bekker LG
    Ann N Y Acad Sci; 2023 Jun; 1524(1):65-86. PubMed ID: 37020354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancing disease genomics beyond COVID-19 and reducing health disparities: what does the future hold for Africa?
    Ibe C; Otu AA; Mnyambwa NP
    Brief Funct Genomics; 2023 May; 22(3):241-249. PubMed ID: 36424843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines for neglected and emerging diseases in Brazil by 2030: the "valley of death" and opportunities for RD&I in Vaccinology 4.0.
    Homma A; Freire MDS; Possas C
    Cad Saude Publica; 2020; 36Suppl 2(Suppl 2):e00128819. PubMed ID: 33111747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Science and Art of Vaccinology During the COVID-19 Pandemic.
    Romero JR; Bernstein HH
    Pediatr Ann; 2020 Dec; 49(12):e506-e508. PubMed ID: 33290567
    [No Abstract]   [Full Text] [Related]  

  • 37. SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments.
    Adesokan A; Obeid MA; Lawal AF
    Ther Deliv; 2022 Mar; 13(3):187-203. PubMed ID: 35195017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidities and the COVID-19 pandemic dynamics in Africa.
    Anjorin AA; Abioye AI; Asowata OE; Soipe A; Kazeem MI; Adesanya IO; Raji MA; Adesanya M; Oke FA; Lawal FJ; Kasali BA; Omotayo MO
    Trop Med Int Health; 2021 Jan; 26(1):2-13. PubMed ID: 33012053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.